3-Cyclopentyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitrile
- Catalog No. :
- ACVEYD481
- CAS No. :
- 1153949-38-2
- Molecular Formula :
- C17H26BN3O2
- Molecular Weight :
- 315.23
IUPAC Name:3-cyclopentyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitrile
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$101.00Login to see priceIn stockInquiry
10g97%$181.00Login to see priceIn stockInquiry
25g97%$353.00Login to see priceIn stockInquiry
100g97%$1129.00Login to see priceInquiryInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | 3-Cyclopentyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitrile |
|---|---|
| IUPAC Name | 3-cyclopentyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitrile |
| MDL No. | MFCD18206946 |
| Molecular Formula | C17H26BN3O2 |
| Molecular Weight | 315.23 |
| SMILES | N#CCC(C1CCCC1)N2N=CC(B3OC(C)(C)C(C)(C)O3)=C2 |
| InChI Key | LJZLJWDLFHJEOC-UHFFFAOYSA-N |
| Synonym | 3-Cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile;racemic 3-cyclopentyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitrile;3-cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propanenitrile;1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;β-Cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-propanenitrile;-Cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-propanenitrile;Ruxolitinib Impurity N5;1-(2-Cyano-1-cyclopentylethyl)-1H-pyrazole-4-boronic Acid Pinacol Ester |
| CAS No. | 1153949-38-2 |
| PubChem CID | 59420165 |
Safety Data
- Pictogram
- Signal Word
- Warning
- Hazard Statement(s)
- H302-H315-H319-H335
- Precautionary Statement(s)
- P261-P305+P351+P338

